<PubmedArticle><MedlineCitation Status="PubMed-not-MEDLINE" Owner="NLM"><PMID Version="1">39416020</PMID><DateRevised><Year>2024</Year><Month>10</Month><Day>24</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Electronic">2692-8205</ISSN><JournalIssue CitedMedium="Internet"><PubDate><Year>2024</Year><Month>Oct</Month><Day>07</Day></PubDate></JournalIssue><Title>bioRxiv : the preprint server for biology</Title><ISOAbbreviation>bioRxiv</ISOAbbreviation></Journal><ArticleTitle>Chronic infections can generate SARS-CoV-2-like bursts of viral evolution without epistasis.</ArticleTitle><ELocationID EIdType="pii" ValidYN="Y">2024.10.06.616878</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1101/2024.10.06.616878</ELocationID><Abstract><AbstractText>Multiple SARS-CoV-2 variants have arisen during the first years of the pandemic, often bearing many new mutations. Several explanations have been offered for the surprisingly sudden emergence of multiple mutations that enhance viral fitness, including cryptic transmission, spillover from animal reservoirs, epistasis between mutations, and chronic infections. Here, we simulated pathogen evolution combining within-host replication and between-host transmission. We found that, under certain conditions, chronic infections can lead to SARS-CoV-2-like bursts of mutations even without epistasis. Chronic infections can also increase the global evolutionary rate of a pathogen even in the absence of clear mutational bursts. Overall, our study supports chronic infections as a plausible origin for highly mutated SARS-CoV-2 variants. More generally, we also describe how chronic infections can influence pathogen evolution under different scenarios.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Rodríguez-Horta</LastName><ForeName>Edwin</ForeName><Initials>E</Initials><Identifier Source="ORCID">0000-0002-6690-629X</Identifier><AffiliationInfo><Affiliation>Department of Computational and Systems Biology, University of Pittsburgh School of Medicine, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Group of Complex Systems and Statistical Physics, Department of Theoretical Physics, Physics Faculty, University of Havana, Cuba.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Strahan</LastName><ForeName>John</ForeName><Initials>J</Initials><Identifier Source="ORCID">0009-0008-7542-8649</Identifier><AffiliationInfo><Affiliation>Department of Chemistry and James Franck Institute, University of Chicago, Chicago, Illinois 60637, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Dinner</LastName><ForeName>Aaron R</ForeName><Initials>AR</Initials><Identifier Source="ORCID">0000-0001-8328-6427</Identifier><AffiliationInfo><Affiliation>Department of Chemistry and James Franck Institute, University of Chicago, Chicago, Illinois 60637, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Barton</LastName><ForeName>John P</ForeName><Initials>JP</Initials><Identifier Source="ORCID">0000-0003-1467-421X</Identifier><AffiliationInfo><Affiliation>Department of Computational and Systems Biology, University of Pittsburgh School of Medicine, USA.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>R35 GM136381</GrantID><Acronym>GM</Acronym><Agency>NIGMS NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>R35 GM138233</GrantID><Acronym>GM</Acronym><Agency>NIGMS NIH HHS</Agency><Country>United States</Country></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D000076942">Preprint</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2024</Year><Month>10</Month><Day>07</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>bioRxiv</MedlineTA><NlmUniqueID>101680187</NlmUniqueID><ISSNLinking>2692-8205</ISSNLinking></MedlineJournalInfo></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="pubmed"><Year>2024</Year><Month>10</Month><Day>17</Day><Hour>10</Hour><Minute>5</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2024</Year><Month>10</Month><Day>17</Day><Hour>10</Hour><Minute>6</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2024</Year><Month>10</Month><Day>17</Day><Hour>4</Hour><Minute>48</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2024</Year><Month>10</Month><Day>16</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">39416020</ArticleId><ArticleId IdType="pmc">PMC11482859</ArticleId><ArticleId IdType="doi">10.1101/2024.10.06.616878</ArticleId><ArticleId IdType="pii">2024.10.06.616878</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Mascola J. R., Graham B. S. &amp; Fauci A. S.
SARS-CoV-2 Viral Variants—Tackling a Moving Target. JAMA
325, 1261–1262 (2021). URL https://doi.org/10.1001/jama.2021.2088. https://jamanetwork.com/journals/jama/articlepdf/2776542/jama_mascola_2021_ed_210014_1617663063.80169.pdf.
</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jama.2021.2088</ArticleId><ArticleId IdType="pubmed">33571363</ArticleId></ArticleIdList></Reference><Reference><Citation>Peacock T. P., Penrice-Randal R., Hiscox J. A. &amp; Barclay W. S. Sars-cov-2 one year on: evidence for ongoing viral adaptation. J. Gen. Virol. 102 (2021). URL 10.1099/jgv.0.001584.</Citation><ArticleIdList><ArticleId IdType="doi">10.1099/jgv.0.001584</ArticleId><ArticleId IdType="pmc">PMC8290271</ArticleId><ArticleId IdType="pubmed">33855951</ArticleId></ArticleIdList></Reference><Reference><Citation>Harvey W. T. et al. Sars-cov-2 variants, spike mutations and immune escape. Nature Reviews Microbiology 19, 409–424 (2021). URL 10.1038/s41579-021-00573-0.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41579-021-00573-0</ArticleId><ArticleId IdType="pmc">PMC8167834</ArticleId><ArticleId IdType="pubmed">34075212</ArticleId></ArticleIdList></Reference><Reference><Citation>Tabatabai M.
et al.
An analysis of covid-19 mortality during the dominancy of alpha, delta, and omicron in the usa. Journal of Primary Care &amp; Community Health
14, 21501319231170164 (2023). URL https://doi.org/10.1177/21501319231170164. https://doi.org/10.1177/21501319231170164.</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/21501319231170164</ArticleId><ArticleId IdType="doi">10.1177/21501319231170164</ArticleId><ArticleId IdType="pmc">PMC10125879</ArticleId><ArticleId IdType="pubmed">37083205</ArticleId></ArticleIdList></Reference><Reference><Citation>Salehi-Vaziri M. et al. The ins and outs of sars-cov-2 variants of concern (vocs). Archives of Virology 167, 327–344 (2022). URL 10.1007/s00705-022-05365-2.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00705-022-05365-2</ArticleId><ArticleId IdType="pmc">PMC8795292</ArticleId><ArticleId IdType="pubmed">35089389</ArticleId></ArticleIdList></Reference><Reference><Citation>Carabelli A. M. et al. Sars-cov-2 variant biology: immune escape, transmission and fitness. Nature Reviews Microbiology 21, 162–177 (2023). URL 10.1038/s41579-022-00841-7.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41579-022-00841-7</ArticleId><ArticleId IdType="pmc">PMC9847462</ArticleId><ArticleId IdType="pubmed">36653446</ArticleId></ArticleIdList></Reference><Reference><Citation>Braun K. M. et al. Acute sars-cov-2 infections harbor limited within-host diversity and transmit via tight transmission bottlenecks. PLOS Pathogens 17, 1–26 (2021). URL 10.1371/journal.ppat.1009849.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.ppat.1009849</ArticleId><ArticleId IdType="pmc">PMC8412271</ArticleId><ArticleId IdType="pubmed">34424945</ArticleId></ArticleIdList></Reference><Reference><Citation>Bendall E. E. et al. Rapid transmission and tight bottlenecks constrain the evolution of highly transmissible sars-cov-2 variants. Nature Communications 14, 272 (2023). URL 10.1038/s41467-023-36001-5.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41467-023-36001-5</ArticleId><ArticleId IdType="pmc">PMC9844183</ArticleId><ArticleId IdType="pubmed">36650162</ArticleId></ArticleIdList></Reference><Reference><Citation>Markov P. V. et al. The evolution of SARS-CoV-2. Nature Reviews Microbiology 21, 361–379 (2023). URL 10.1038/s41579-023-00878-2.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41579-023-00878-2</ArticleId><ArticleId IdType="pubmed">37020110</ArticleId></ArticleIdList></Reference><Reference><Citation>Davis J. T. et al. Cryptic transmission of sars-cov-2 and the first covid-19 wave. Nature 600, 127–132 (2021). URL 10.1038/s41586-021-04130-w.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41586-021-04130-w</ArticleId><ArticleId IdType="pmc">PMC8636257</ArticleId><ArticleId IdType="pubmed">34695837</ArticleId></ArticleIdList></Reference><Reference><Citation>Wilkinson E.
et al.
A year of genomic surveillance reveals how the sars-cov-2 pandemic unfolded in africa. Science
374, 423–431 (2021). URL https://www.science.org/doi/abs/10.1126/science.abj4336. https://www.science.org/doi/pdf/10.1126/science.abj4336.
</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/science.abj4336</ArticleId><ArticleId IdType="doi">10.1126/science.abj4336</ArticleId><ArticleId IdType="pmc">PMC7613315</ArticleId><ArticleId IdType="pubmed">34672751</ArticleId></ArticleIdList></Reference><Reference><Citation>Adepoju P.
Challenges of sars-cov-2 genomic surveillance in africa. The Lancet Microbe
2, e139 (2021). URL https://www.sciencedirect.com/science/article/pii/S2666524721000653.
</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8009639</ArticleId><ArticleId IdType="pubmed">33817677</ArticleId></ArticleIdList></Reference><Reference><Citation>Lu L. et al. Adaptation, spread and transmission of sars-cov-2 in farmed minks and associated humans in the netherlands. Nature Communications 12, 6802 (2021). URL 10.1038/s41467-021-27096-9.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41467-021-27096-9</ArticleId><ArticleId IdType="pmc">PMC8611045</ArticleId><ArticleId IdType="pubmed">34815406</ArticleId></ArticleIdList></Reference><Reference><Citation>Bashor L.
et al.
Sars-cov-2 evolution in animals suggests mechanisms for rapid variant selection. Proceedings of the National Academy of Sciences
118, e2105253118 (2021). URL https://www.pnas.org/doi/abs/10.1073/pnas.2105253118. https://www.pnas.org/doi/pdf/10.1073/pnas.2105253118.</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.2105253118</ArticleId><ArticleId IdType="doi">10.1073/pnas.2105253118</ArticleId><ArticleId IdType="pmc">PMC8612357</ArticleId><ArticleId IdType="pubmed">34716263</ArticleId></ArticleIdList></Reference><Reference><Citation>Hale V. L. et al. Sars-cov-2 infection in free-ranging white-tailed deer. Nature 602, 481–486 (2022). URL 10.1038/s41586-021-04353-x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41586-021-04353-x</ArticleId><ArticleId IdType="pmc">PMC8857059</ArticleId><ArticleId IdType="pubmed">34942632</ArticleId></ArticleIdList></Reference><Reference><Citation>Pickering B. et al. Divergent sars-cov-2 variant emerges in white-tailed deer with deer-to-human transmission. Nature Microbiology 7, 2011–2024 (2022). URL 10.1038/s41564-022-01268-9.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41564-022-01268-9</ArticleId><ArticleId IdType="pmc">PMC9712111</ArticleId><ArticleId IdType="pubmed">36357713</ArticleId></ArticleIdList></Reference><Reference><Citation>Smith C. A. &amp; Ashby B.
Antigenic evolution of SARS-CoV-2 in immunocompromised hosts. Evolution, Medicine, and Public Health
11, 90–100 (2022). URL https://doi.org/10.1093/emph/eoac037. https://academic.oup.com/emph/article-pdf/11/1/90/49701865/eoac037.pdf.
</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/emph/eoac037</ArticleId><ArticleId IdType="pmc">PMC10061940</ArticleId><ArticleId IdType="pubmed">37007166</ArticleId></ArticleIdList></Reference><Reference><Citation>Ghafari M., Liu Q., Dhillon A., Katzourakis A. &amp; Weissman D. B. Investigating the evolutionary origins of the first three sars-cov-2 variants of concern. Frontiers in Virology 2 (2022).</Citation></Reference><Reference><Citation>Martin D. P.
et al.
Selection Analysis Identifies Clusters of Unusual Mutational Changes in Omicron Lineage BA.1 That Likely Impact Spike Function. Molecular Biology and Evolution
39, msac061 (2022). URL https://doi.org/10.1093/molbev/msac061. https://academic.oup.com/mbe/article-pdf/39/4/msac061/43374245/msac061.pdf.
</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/molbev/msac061</ArticleId><ArticleId IdType="pmc">PMC9037384</ArticleId><ArticleId IdType="pubmed">35325204</ArticleId></ArticleIdList></Reference><Reference><Citation>Zahradník J. et al. Sars-cov-2 variant prediction and antiviral drug design are enabled by rbd in vitro evolution. Nature Microbiology 6, 1188–1198 (2021). URL 10.1038/s41564-021-00954-4.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41564-021-00954-4</ArticleId><ArticleId IdType="pubmed">34400835</ArticleId></ArticleIdList></Reference><Reference><Citation>Choi B.
et al.
Persistence and evolution of sars-cov-2 in an immunocompromised host. New England Journal of Medicine
383, 2291–2293 (2020). URL https://doi.org/10.1056/NEJMc2031364. https://doi.org/10.1056/NEJMc2031364.
</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJMc2031364</ArticleId><ArticleId IdType="doi">10.1056/NEJMc2031364</ArticleId><ArticleId IdType="pmc">PMC7673303</ArticleId><ArticleId IdType="pubmed">33176080</ArticleId></ArticleIdList></Reference><Reference><Citation>Avanzato V. A.
et al.
Case study: Prolonged infectious sars-cov-2 shedding from an asymptomatic immunocompromised individual with cancer. Cell
183, 1901–1912.e9 (2020). URL https://www.sciencedirect.com/science/article/pii/S0092867420314562.
</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7640888</ArticleId><ArticleId IdType="pubmed">33248470</ArticleId></ArticleIdList></Reference><Reference><Citation>Clark S. A. et al. Sars-cov-2 evolution in an immunocompromised host reveals shared neutralization escape mechanisms. Cell 184, 2605–2617.e18 (2021). URL 10.1016/j.cell.2021.03.027.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cell.2021.03.027</ArticleId><ArticleId IdType="pmc">PMC7962548</ArticleId><ArticleId IdType="pubmed">33831372</ArticleId></ArticleIdList></Reference><Reference><Citation>Lee C. Y.
et al.
Prolonged SARS-CoV-2 Infection in Patients with Lymphoid Malignancies. Cancer Discovery
12, 62–73 (2022). URL https://doi.org/10.1158/2159-8290.CD-21-1033. https://aacrjournals.org/cancerdiscovery/article-pdf/12/1/62/3194898/62.pdf.
</Citation><ArticleIdList><ArticleId IdType="doi">10.1158/2159-8290.CD-21-1033</ArticleId><ArticleId IdType="pmc">PMC8758535</ArticleId><ArticleId IdType="pubmed">34753749</ArticleId></ArticleIdList></Reference><Reference><Citation>Chaguza C. et al. Accelerated SARS-CoV-2 intrahost evolution leading to distinct genotypes during chronic infection. Cell Rep. Med. 4, 100943 (2023).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9906997</ArticleId><ArticleId IdType="pubmed">36791724</ArticleId></ArticleIdList></Reference><Reference><Citation>Wilkinson S. A. J.
et al.
Recurrent SARS-CoV-2 mutations in immunodeficient patients. Virus Evolution
8, veac050 (2022). URL https://doi.org/10.1093/ve/veac050. https://academic.oup.com/ve/article-pdf/8/2/veac050/48422645/veac050.pdf.
</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/ve/veac050</ArticleId><ArticleId IdType="pmc">PMC9384748</ArticleId><ArticleId IdType="pubmed">35996593</ArticleId></ArticleIdList></Reference><Reference><Citation>Kemp S. A. et al. SARS-CoV-2 evolution during treatment of chronic infection. Nature 592, 277–282 (2021). URL 10.1038/s41586-021-03291-y.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41586-021-03291-y</ArticleId><ArticleId IdType="pmc">PMC7610568</ArticleId><ArticleId IdType="pubmed">33545711</ArticleId></ArticleIdList></Reference><Reference><Citation>R, K. &amp; A, S. Antigenic escape is accelerated by the presence of immunocompromised hosts. Proceedings of the Royal Society B: Biological Sciences 289 (2022).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9653221</ArticleId><ArticleId IdType="pubmed">36350217</ArticleId></ArticleIdList></Reference><Reference><Citation>Van Egeren D. et al. Controlling long-term sars-cov-2 infections can slow viral evolution and reduce the risk of treatment failure. Scientific Reports 11, 22630 (2021). URL 10.1038/s41598-021-02148-8.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41598-021-02148-8</ArticleId><ArticleId IdType="pmc">PMC8604936</ArticleId><ArticleId IdType="pubmed">34799659</ArticleId></ArticleIdList></Reference><Reference><Citation>Lee B.
et al.
Inferring effects of mutations on sars-cov-2 transmission from genomic surveillance data. medRxiv (2022). URL https://www.medrxiv.org/content/early/2022/01/14/2021.12.31.21268591. https://www.medrxiv.org/content/early/2022/01/14/2021.12.31.21268591.full.pdf.</Citation></Reference><Reference><Citation>Eigen M., McCaskill J. &amp; Schuster P. Molecular quasi-species. The Journal of Physical Chemistry 92, 6881–6891 (1988).</Citation></Reference><Reference><Citation>Coffin J. M. Hiv population dynamics in vivo: implications for genetic variation, pathogenesis, and therapy. Science 267, 483–489 (1995).</Citation><ArticleIdList><ArticleId IdType="pubmed">7824947</ArticleId></ArticleIdList></Reference><Reference><Citation>Domingo E., Sheldon J. &amp; Perales C. Viral quasispecies evolution. Microbiology and Molecular Biology Reviews 76, 159–216 (2012).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3372249</ArticleId><ArticleId IdType="pubmed">22688811</ArticleId></ArticleIdList></Reference><Reference><Citation>Ewens W. Mathematical Population Genetics 1: Theoretical Introduction (Springer Science and Business Media, 2012).</Citation></Reference><Reference><Citation>Wargo A. R. &amp; Kurath G.
Viral fitness: definitions, measurement, and current insights. Current Opinion in Virology
2, 538–545 (2012). URL https://www.sciencedirect.com/science/article/pii/S1879625712001290. Virus evolution / Antivirals and resistance.
</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7102723</ArticleId><ArticleId IdType="pubmed">22986085</ArticleId></ArticleIdList></Reference><Reference><Citation>Allen T. M. et al. Selection, transmission, and reversion of an antigen-processing cytotoxic t-lymphocyte escape mutation in human immunodeficiency virus type 1 infection. Journal of virology 78, 7069–7078 (2004).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC421658</ArticleId><ArticleId IdType="pubmed">15194783</ArticleId></ArticleIdList></Reference><Reference><Citation>Leslie A. et al. Hiv evolution: Ctl escape mutation and reversion after transmission. Nature medicine 10, 282–289 (2004).</Citation><ArticleIdList><ArticleId IdType="pubmed">14770175</ArticleId></ArticleIdList></Reference><Reference><Citation>Friedrich T. C. et al. Reversion of ctl escape–variant immunodeficiency viruses in vivo. Nature medicine 10, 275–281 (2004).</Citation><ArticleIdList><ArticleId IdType="pubmed">14966520</ArticleId></ArticleIdList></Reference><Reference><Citation>Zanini F. et al. Population genomics of intrapatient hiv-1 evolution. Elife 4, e11282 (2015).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4718817</ArticleId><ArticleId IdType="pubmed">26652000</ArticleId></ArticleIdList></Reference><Reference><Citation>Gao Y. &amp; Barton J. P. A binary trait model reveals the fitness effects of hiv-1 escape from t cell responses. bioRxiv (2024).</Citation></Reference><Reference><Citation>Korber B.
et al.
Tracking changes in sars-cov-2 spike: Evidence that d614g increases infectivity of the covid-19 virus. Cell
182, 812–827.e19 (2020). URL https://www.sciencedirect.com/science/article/pii/S0092867420308205.
</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7332439</ArticleId><ArticleId IdType="pubmed">32697968</ArticleId></ArticleIdList></Reference><Reference><Citation>Yurkovetskiy L.
et al.
Structural and functional analysis of the d614g sars-cov-2 spike protein variant. Cell
183, 739–751.e8 (2020). URL https://www.sciencedirect.com/science/article/pii/S0092867420312290.
</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7492024</ArticleId><ArticleId IdType="pubmed">32991842</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu Y. et al. The n501y spike substitution enhances sars-cov-2 infection and transmission. Nature 602, 294–299 (2022). URL 10.1038/s41586-021-04245-0.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41586-021-04245-0</ArticleId><ArticleId IdType="pmc">PMC8900207</ArticleId><ArticleId IdType="pubmed">34818667</ArticleId></ArticleIdList></Reference><Reference><Citation>Irwin J. A distribution arising in the study of infectious diseases. Biometrika 41, 266–268 (1954).</Citation></Reference><Reference><Citation>Griffiths D. Maximum likelihood estimation for the beta-binomial distribution and an application to the household distribution of the total number of cases of a disease. Biometrics 29, 637–648 (1973).</Citation><ArticleIdList><ArticleId IdType="pubmed">4785230</ArticleId></ArticleIdList></Reference><Reference><Citation>Lipsitch M. et al. Transmission dynamics and control of severe acute respiratory syndrome. Science 300, 1966–1970 (2003).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2760158</ArticleId><ArticleId IdType="pubmed">12766207</ArticleId></ArticleIdList></Reference><Reference><Citation>Lloyd-Smith J. O., Schreiber S. J., Kopp P. E. &amp; Getz W. M. Superspreading and the effect of individual variation on disease emergence. Nature 438, 355–359 (2005).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7094981</ArticleId><ArticleId IdType="pubmed">16292310</ArticleId></ArticleIdList></Reference><Reference><Citation>Althouse B. M. et al. Superspreading events in the transmission dynamics of SARS-CoV-2: Opportunities for interventions and control. PLOS Biology 18, 1–13 (2020).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7685463</ArticleId><ArticleId IdType="pubmed">33180773</ArticleId></ArticleIdList></Reference><Reference><Citation>Bar-On Y. M., Flamholz A., Phillips R. &amp; Milo R. Science forum: Sars-cov-2 (covid-19) by the numbers. eLife 9, e57309 (2020). URL 10.7554/eLife.57309.</Citation><ArticleIdList><ArticleId IdType="doi">10.7554/eLife.57309</ArticleId><ArticleId IdType="pmc">PMC7224694</ArticleId><ArticleId IdType="pubmed">32228860</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen D. et al. Inferring time-varying generation time, serial interval, and incubation period distributions for covid-19. Nature Communications 13, 7727 (2022). URL 10.1038/s41467-022-35496-8.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41467-022-35496-8</ArticleId><ArticleId IdType="pmc">PMC9747081</ArticleId><ArticleId IdType="pubmed">36513688</ArticleId></ArticleIdList></Reference><Reference><Citation>Hart W. S. et al. Inference of the sars-cov-2 generation time using uk household data. eLife 11, e70767 (2022). URL 10.7554/eLife.70767.</Citation><ArticleIdList><ArticleId IdType="doi">10.7554/eLife.70767</ArticleId><ArticleId IdType="pmc">PMC8967386</ArticleId><ArticleId IdType="pubmed">35138250</ArticleId></ArticleIdList></Reference><Reference><Citation>Doud M. B., Ashenberg O. &amp; Bloom J. D. Site-specific amino acid preferences are mostly conserved in two closely related protein homologs. Molecular biology and evolution 32, 2944–2960 (2015).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4626756</ArticleId><ArticleId IdType="pubmed">26226986</ArticleId></ArticleIdList></Reference><Reference><Citation>Haddox H. K., Dingens A. S., Hilton S. K., Overbaugh J. &amp; Bloom J. D. Mapping mutational effects along the evolutionary landscape of hiv envelope. Elife 7, e34420 (2018).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5910023</ArticleId><ArticleId IdType="pubmed">29590010</ArticleId></ArticleIdList></Reference><Reference><Citation>Shimagaki K. S., Lynch R. M. &amp; Barton J. P. Parallel hiv-1 evolutionary dynamics in humans and rhesus macaques who develop broadly neutralizing antibodies. bioRxiv (2024).</Citation></Reference><Reference><Citation>Ball F. et al. Seven challenges for metapopulation models of epidemics, including households models. Epidemics 10, 63–67 (2015).</Citation><ArticleIdList><ArticleId IdType="pubmed">25843386</ArticleId></ArticleIdList></Reference><Reference><Citation>Stadler T. et al. Estimating the basic reproductive number from viral sequence data. Molecular biology and evolution 29, 347–357 (2012).</Citation><ArticleIdList><ArticleId IdType="pubmed">21890480</ArticleId></ArticleIdList></Reference><Reference><Citation>Volz E. M., Koopman J. S., Ward M. J., Brown A. L. &amp; Frost S. D. Simple epidemiological dynamics explain phylogenetic clustering of hiv from patients with recent infection. PLoS computational biology 8, e1002552 (2012).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3386305</ArticleId><ArticleId IdType="pubmed">22761556</ArticleId></ArticleIdList></Reference><Reference><Citation>Volz E. M., Koelle K. &amp; Bedford T. Viral phylodynamics. PLoS computational biology 9, e1002947 (2013).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3605911</ArticleId><ArticleId IdType="pubmed">23555203</ArticleId></ArticleIdList></Reference><Reference><Citation>Frost S. D. et al. Eight challenges in phylodynamic inference. Epidemics 10, 88–92 (2015).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4383806</ArticleId><ArticleId IdType="pubmed">25843391</ArticleId></ArticleIdList></Reference><Reference><Citation>Bar-On Y. M., Flamholz A., Phillips R. &amp; Milo R. Science forum: Sars-cov-2 (covid-19) by the numbers. eLife 9, e57309 (2020). URL 10.7554/eLife.57309.</Citation><ArticleIdList><ArticleId IdType="doi">10.7554/eLife.57309</ArticleId><ArticleId IdType="pmc">PMC7224694</ArticleId><ArticleId IdType="pubmed">32228860</ArticleId></ArticleIdList></Reference><Reference><Citation>Lee B.
et al.
Inferring effects of mutations on sars-cov-2 transmission from genomic surveillance data. medRxiv (2022). URL https://www.medrxiv.org/content/early/2022/01/14/2021.12.31.21268591. https://www.medrxiv.org/content/early/2022/01/14/2021.12.31.21268591.full.pdf.</Citation></Reference><Reference><Citation>Wegehaupt O., Endo A. &amp; Vassall A. Superspreading, overdispersion and their implications in the sars-cov-2 (covid-19) pandemic: a systematic review and meta-analysis of the literature. BMC Public Health 23, 1003 (2023). URL 10.1186/s12889-023-15915-1.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12889-023-15915-1</ArticleId><ArticleId IdType="pmc">PMC10227392</ArticleId><ArticleId IdType="pubmed">37254143</ArticleId></ArticleIdList></Reference><Reference><Citation>Savitzky A. &amp; Golay M. J. E. Smoothing and differentiation of data by simplified least squares procedures. Analytical Chemistry 36, 1627–1639 (1964). URL 10.1021/ac60214a047.</Citation><ArticleIdList><ArticleId IdType="doi">10.1021/ac60214a047</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle>